Webinar
Scaling Biotech: Strategies to Overcome Growth Hurdles
Webinar panelists:
Brendan McCorkleCEO, SciNote
Mark FortnerCEO, Aspen Biosciences
About this webinar
Scaling up biotech operations poses unique challenges due to its inherent complexities. It involves navigating intricate scientific processes, stringent regulations, resource constraints, and more. If not managed properly, this can lead to delays in product development, compromised quality, even financial consequences – and ultimately hinder the company’s growth and competitiveness.
So, how can you effectively tackle these challenges, and successfully manage the growth of your organization?
Join us for a conversation with SciNote CEO Brendan McCorkle and Aspen Biosciences Founder/CEO Mark Fortner, both of whom have worked closely with biotech companies scaling up their operations. They will discuss the common challenges biotech companies face when managing scaling up, strategies to tackle these challenges, and real-world examples of successes.
In this webinar, you’ll learn about:
- Overcoming Communication Hurdles: Learn how to foster efficient communication and collaboration, crucial for scaling biotech operations.
- Navigating Growth Challenges: Explore essential tools and strategies tailored to biotech needs, the importance of solution scalability and integration, and the impact of AI.
- Success Stories: Explore real-world examples of biotech companies successfully scaling their operations, showcasing strategies and tooling approaches that have enabled them to overcome growth hurdles.
Are you ready to discover the secrets behind successful scaling in the biotech industry? Join us as we delve into practical strategies and inspiring success stories that can help your organization thrive.
Watch it now
05:50 Challenges in scaling biotech ops
08:41 Importance of FAIR data & communication breakdowns
12:56 Tech tools for biotech project management
15:33 Key considerations in tool selection
19:00 All-in-One vs. Tech Stack
24:48 AI and ML in biotech
29:50 Successful scale up and collaborations
32:15 Data security considerations
33:40 Advice for biotech entrepreneurs
35:26 Q&A
More about the speakers
Brendan McCorkle, CEO, SciNote
For the last 15 + years working in technology Brendan has started and grown multiple investor backed businesses, raised over $20MM in Venture backing, negotiated and managed a technology transfer out of a 2B+ healthcare system and ran a successful turnaround (6x revenue and 4x margin in 2.5 years). He regularly mentors current and aspiring entrepreneurs as they work to find product-market fit, fundraise, and navigate the ebbs and flows of people management through rapid growth. He has built Enterprise SaaS business as well as a Data Science/Data Engineering heavy software consultancy. Before getting into technology he was a Paramedic and a Mental Health Technician for many years, participating in one of the first rollouts of EHR technology in the US.
Brendan pursued advanced education in the area of Technology Management at the University of Pennsylvania, receiving a Master’s of Science in Technology Management in a program jointly sponsored by Wharton and the School of Engineering. This program was created to support and develop executives sitting at the intersection of technology and business, which is where he has spent the bulk of his career.
Mark Fortner, CEO, Aspen Biosciences
Mark Fortner is a seasoned entrepreneur and innovator with over 20 years of leadership experience in pharmaceutical and biotech research informatics. As the CEO of Aspen Biosciences, he spearheads the development of tailored solutions in genomics, proteomics, and cheminformatics, employing agile, user-driven methodologies. Mark’s expertise spans various domains, including drug discovery, cancer biology, research informatics and knowledge management. His innovative approach to software development has led to the creation of cutting-edge applications such as Cocktail, a polypharmacy drug development tool for mapping the drug target space in pancreatic cancer; and most recently, Pipeline, a platform designed to help scientists plan, manage and execute drug discovery programs. Pipeline supports the drug discovery process from Target Identification to Lead Optimization stages with modules that provide scientists with the tools needed to manage target and project information, design & synthesize protein targets for screening campaigns, design & synthesize compound libraries, and test those molecules in a wide array of assays. Its workflows allow scientists to track and manage the process across both internal and CRO-managed steps.
With a rich history in both early-stage startups and established pharmaceutical companies like Takeda and Pfizer, Mark has honed his skills in business strategy, software development, and project management. His contributions include developing advanced software applications for drug target identification and validation, as well as implementing innovative solutions to streamline drug discovery processes. Mark’s passion for leveraging technology to solve complex problems in the life sciences industry underscores his commitment to driving innovation and advancing research capabilities. As a visionary leader, he continues to pioneer transformative solutions that empower scientists and researchers worldwide.
About Aspen Biosciences
Aspen Biosciences is a leading provider of software solutions for drug discovery, pharmaceutical, and cancer research organizations.
With our expertise in life sciences, drug discovery, and agile software development, we empower organizations to enhance their discovery speed, expand project capacity, and streamline data management in drug discovery programs. Our comprehensive services encompass informatics roadmaps, customized software solutions, ELN/LIMS implementations, and system integrations.
Our goal is to accelerate life science R&D by leveraging existing software tools and platforms, while delivering tailored, cost-effective integrated solutions.
Try SciNote Premium for yourself
Discover what SciNote can do for you. Get a proof of concept with our premium support and custom-tailored experience.
SciNote Reviews
Connect with us
SciNote Newsletter
Receive SciNote ELN news, webinars and articles.